Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Patients often combine Tesamorelin with other peptides as part of a physician-designed weight management protocol
The large telehealth and compounding companies could fund this research to help people become more comfortable with using this compound
It is not a tirzepatide side effect
100% online, no insurance needed
Published pre-clinical citations on the product page include research by Sikiric et al
Pathway 2: Chronic weight management (approved November 2023, marketed as Zepbound) You qualify if you have: BMI 30 kg/m or higher (obesity), OR BMI 27 kg/m or higher (overweight) with at least one weight-related comorbid condition The weight management indication uses the brand name Zepbound rather than Mounjaro, but the active ingredient (tirzepatide) and dosing are identical
